BACKGROUND: Acute tryptophan depletion can induce a transient reappearance of depressive symptoms in recovered depressed patients. The neurochemical mechanism is thought to be impairment of brain serotonin neurotransmission, but the neuropsychologic mechanisms underlying the effect are unclear. METHODS: To assess whether low-dose tryptophan depletion can tease out the psychological mechanisms sensitive to substrate depletion in vulnerable subjects without inducing mood changes, a between-subjects randomized design was used. Recovered depressed patients (n = 24) and healthy volunteers (n = 24) were administered while fasting either a tryptophan-free or a control mixture, containing 31.2 and 33.2 g of amino acids, respectively. Objective and subjective ratings of mood were made before and 5 hours after ingestion; at the latter time point, cognitive and emotional processing were also assessed. RESULTS: Low-dose tryptophan depletion did not affect mood. Significant changes in emotional and cognitive processing occurred in the recovered depressed group, however, and to a lesser extent in the healthy volunteers. The profile of effects seen in the recovered patients suggested a return of the impairments seen in acute depression. CONCLUSIONS: Our data suggest that low-dose tryptophan depletion permits investigation of the cognitive correlates of acute reductions in brain serotonin in populations vulnerable to depression and in healthy volunteers, without causing depressive symptoms.
RCT Entities:
BACKGROUND: Acute tryptophan depletion can induce a transient reappearance of depressive symptoms in recovered depressedpatients. The neurochemical mechanism is thought to be impairment of brain serotonin neurotransmission, but the neuropsychologic mechanisms underlying the effect are unclear. METHODS: To assess whether low-dose tryptophan depletion can tease out the psychological mechanisms sensitive to substrate depletion in vulnerable subjects without inducing mood changes, a between-subjects randomized design was used. Recovered depressedpatients (n = 24) and healthy volunteers (n = 24) were administered while fasting either a tryptophan-free or a control mixture, containing 31.2 and 33.2 g of amino acids, respectively. Objective and subjective ratings of mood were made before and 5 hours after ingestion; at the latter time point, cognitive and emotional processing were also assessed. RESULTS: Low-dose tryptophan depletion did not affect mood. Significant changes in emotional and cognitive processing occurred in the recovered depressed group, however, and to a lesser extent in the healthy volunteers. The profile of effects seen in the recovered patients suggested a return of the impairments seen in acute depression. CONCLUSIONS: Our data suggest that low-dose tryptophan depletion permits investigation of the cognitive correlates of acute reductions in brain serotonin in populations vulnerable to depression and in healthy volunteers, without causing depressive symptoms.
Authors: Eileen Daly; Quinton Deeley; Brian Hallahan; Michael Craig; Michael Brammer; Melissa Lamar; Anthony Cleare; Vincent Giampietro; Christine Ecker; Lisa Page; Fiona Toal; Mary L Phillips; Simon Surguladze; Declan G M Murphy Journal: Psychopharmacology (Berl) Date: 2010-04-28 Impact factor: 4.530
Authors: Hamid A Alhaj; Matthew Selman; Victoria Jervis; Jacqui Rodgers; Stephen Barton; R Hamish McAllister-Williams Journal: Psychopharmacology (Berl) Date: 2012-07 Impact factor: 4.530
Authors: Oliver J Robinson; Cassie Overstreet; Philip S Allen; Alison Letkiewicz; Katherine Vytal; Daniel S Pine; Christian Grillon Journal: Neuroimage Date: 2013-04-11 Impact factor: 6.556
Authors: Michael T Treadway; Joshua W Buckholtz; Ashley N Schwartzman; Warren E Lambert; David H Zald Journal: PLoS One Date: 2009-08-12 Impact factor: 3.240